Overview

Who we are

Aagamiseq is a forward-thinking biotechnology startup at the forefront of innovation in solid-state pore technologies. Specializing in advanced single-entity multiplexed sensing, we are committed to transforming healthcare and diagnostics by providing cost-effective, scalable solutions for detecting even trace amounts of disease-related biomarkers.

As a comprehensive provider in the nanopore and micropore space, we deliver an integrated portfolio of products and services, including state-of-the-art readout instruments, customizable solid-state chips, flow cells, diagnostic protocols, and essential consumables.

Driven by a passion for precision and innovation, our cutting-edge technology and holistic approach empower researchers and clinicians to achieve unparalleled accuracy in diagnostics, fostering scientific progress and elevating global healthcare standards.

What we do

At Aagamiseq, we deliver comprehensive solutions for every facet of nanopore and micropore technology. Our offerings are designed to empower researchers and clinicians with cutting-edge tools and resources, including:

• Solid-State Chips: Customizable pore sizes for precise, single-entity characterization.

• Advanced Instruments: State-of-the-art devices for reliable diagnostic and analytical applications.

• Diagnostic Protocols: Disease-specific methodologies tailored for accurate and efficient testing.

• Consumables: High-quality materials essential for seamless diagnostic workflows.

• Integrated Software Solutions: User-friendly platforms bundled with our hardware for streamlined operations.

As active contributors to the nanopore community, we address compatibility challenges between hardware and software, striving to standardize practices and enhance efficiency. Our mission is to drive innovation, advance nanopore science, and enable more robust and reliable diagnostic and research applications.

Why we exist

At Aagamiseq, we believe that accurate and early diagnosis is the cornerstone of effective medical care. However, many diseases remain elusive in their early stages, when treatment can be most impactful. Traditional diagnostic tools often fall short in detecting these conditions due to the extremely low concentrations of critical biomarkers in biological samples.

The challenges are amplified by the variability of diseases across individuals and the prohibitive cost or inaccessibility of advanced diagnostic methods in many regions. This results in missed or delayed diagnoses, leading to limited treatment options, more aggressive interventions, and diminished quality of life.

We exist to bridge this gap by creating reliable, highly sensitive, and accessible diagnostic solutions that empower healthcare providers to detect diseases earlier and more accurately. Our mission is to transform patient outcomes by enabling timely interventions, improving survival rates, and elevating the standard of care globally. We are committed to advancing healthcare for a healthier future through innovation in nanopore and micropore technology.

Mission and Vision

Mission Statement:

Our mission at Aagamiseq is to revolutionize healthcare diagnostics by developing innovative, reliable, and accessible solutions powered by cutting-edge nanopore and micropore technologies. We are committed to enabling early and accurate detection of diseases, empowering clinicians and researchers with advanced tools, and driving global improvements in healthcare outcomes. Through innovation, collaboration, and a dedication to excellence, we aim to make precise diagnostics affordable and available to all, transforming lives and advancing the frontiers of medical science.

Vision Statement:

At Aagamiseq, our vision is to revolutionize healthcare by making early and accurate disease diagnosis accessible to everyone, regardless of location or resources. We aim to be a global leader in nanopore and micropore technologies, driving advancements in precision diagnostics through innovation and meticulous development.

Our commitment includes continuously improving the quality and sensitivity of our solid-state chips to detect even the most subtle disease markers. We strive to develop and refine diagnostic protocols that are robust, reliable, and tailored to the complexities of diverse conditions.

To enhance usability, we are dedicated to creating intuitive software and automation tools that simplify workflows and empower our customers with seamless, efficient solutions. Additionally, we are passionate about extending the reach of advanced diagnostics to low-resource regions by pioneering frugal methodologies that maintain high accuracy while remaining cost-effective.

Through these efforts, we seek to transform the global healthcare landscape, enabling timely interventions, improving outcomes, and fostering a healthier, more equitable future for all.